 |
|
|
 |
FEREYDOUN DAVATCHI, AHMAD-REZA JAMSHIDI, ARASH TEHRANI BANIHASHEMI, JALEH GHOLAMI, MOHAMMAD HOSSEIN FOROUZANFAR, MASSOOMEH AKHLAGHI, MOJGAN BARGHAMDI, ELHAM NOOROLAHZADEH, ALI-REZA KHABAZI, MANSOOR SALESI, AMIR-HOSSEIN SALARI, MANSOOR KARIMIFAR, KAMAL ESSALAT-MANESH, MEHRZAD HAJIALILOO, MOHSEN SOROOSH, FARHAD FARZAD, HAMID-REZA MOUSSAVI, FARIDEH SAMADI, KOOROSH GHAZNAVI, HOMA ASGHARIFARD, AMIR-HOSSEIN ZANGIABADI, FARHAD SHAHRAM, ABDOLHADI NADJI, MAHMOOD AKBARIAN, and FARHAD GHARIBDOOST
ABSTRACT. Methods. Tehran, with one-ninth of the population of Iran and of mixed ethnic origins, was selected as the field. Subjects were randomly selected from the 22 districts. Interviews were conducted once a week, on the weekend. The 3 phases of stage 1 were done on the same day, in parallel, like the fast-track Community Oriented Program for Control of Rheumatic Diseases (COPCORD). Results. Four thousand ninety-six houses were visited and 10,291 persons were interviewed. Musculoskeletal complaints during the past 7 days were detected in 41.9% of the interviewed subjects. The distribution was: shoulder 14.5%, wrist 10%, hands and fingers 9.4%, hip 7.1%, knee 25.5%, ankle 9.8%, toes 6.1%, cervical spine 13.4%, and dorsal and lumbar spine 21.7%. Degenerative joint diseases were detected in 16.6% of subjects: cervical spondylosis 1.8%, knee osteoarthritis (OA) 15.3%, hand OA 2.9%, and hip OA 0.32%. Low back pain was detected in 15.4% and soft tissue rheumatism in 4.6%. Inflammatory disorders were rheumatoid arthritis 0.33%, seronegative spondyloarthropathies 0.23%, ankylosing spondylitis 0.12%, systemic lupus erythematosus 0.04%, and Behçet's disease 0.08%. Fibromyalgia was detected in 0.69% and gout in 0.13% of the studied population. Conclusion. The large urban COPCORD study in Iran showed a high prevalence of rheumatic complaints in the population over the age of 15 years, 41.9%. Knee OA and low back pain were the most frequent complaints. (J Rheumatol First Release May 1 2008) Key Indexing Terms:
PREVALENCE From the Rheumatology Research Center, Shariati Hospital, Medical Sciences/University of Tehran, Tehran, Iran. Supported by the Ministry of Health and Medical Education and Tehran University for Medical Sciences and Health Services grant number 130/8976. F. Davatchi, MD; A-R. Jamshidi, MD; A. Tehrani Banihashemi, MD; J. Gholami, MD; M.H. Forouzanfar, MD; M. Akhlaghi, MD; M. Barghamdi, MD; E. Noorolahzadeh, MD; A-R. Khabazi, MD; M. Salesi, MD; A-H. Salari, MD; M. Karimifar, MD; K. Essalat-Manesh, MD; M. Hajialiloo, MD; M. Soroosh, MD; F. Farzad, MD; H-R. Moussavi, MD; F. Samadi, MD; K. Ghaznavi, MD; H. Asgharifard, MD; A-H. Zangiabadi, MD; F. Shahram, MD; A. Nadji, MD; M. Akbarian, MD; F. Gharibdoost, MD, Rheumatology Research Center, Shariati Hospital, Medical Sciences/University of Tehran. Address reprint requests to Prof. F. Davatchi, Rheumatology Research Center, Shariati Hospital, Kargar Avenue, Tehran 14114, Iran. E-mail: fddh@davatchi.net Accepted for publication February 11, 2008. |
